New Zealand vs Oman: Statin use vs average non hdl cholesterol levels
New Zealand
3.4
in 2018
Oman
3.4
in 2018
New Zealand rank
75th
Oman rank
75th
Statin use vs average non hdl cholesterol levels over time
- New Zealand
- Oman
How they compare
New Zealand currently reports 3.4 against 3.4 in Oman, a difference of 0.
The two have swapped places 3 times across 39 shared years of data; in 1980 it was New Zealand ahead.
New Zealand ranks 75th and Oman ranks 75th of 191 countries.
New Zealand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | New Zealand | Oman | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 4.48 | 3.48 | 1 | New Zealand |
| 1990s | 4.31 | 3.77 | 0.54 | New Zealand |
| 2000s | 3.92 | 3.74 | 0.18 | New Zealand |
| 2010s | 3.53 | 3.53 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs average non hdl cholesterol levels, New Zealand or Oman?
- New Zealand, at 3.4 against 3.4 in Oman as of 2018.
- What is the difference in statin use vs average non hdl cholesterol levels between New Zealand and Oman?
- 0, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Oman?
- 39 years are reported by both, from 1980 to 2018.
- How do New Zealand and Oman rank globally for statin use vs average non hdl cholesterol levels?
- New Zealand ranks 75th and Oman ranks 75th of 191 countries.
- Where does this data come from?
- Our World in Data, published as Statin use vs average non hdl cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.